Viral arthritis.
The role of viruses in the development of acute and chronic arthritis is complex, because viruses are ubiquitous, and all human beings are occasionally afflicted by viral infections. In general, most viral infections are acute and self-limiting and survive by infecting one susceptible host, then moving on to another. Some viruses establish prolonged latency in the host after acute infection, whereas other agents produce chronic infections following the primary stage. The mechanisms whereby these infections produce arthritis are diverse and still poorly understood, but are clearly influenced by both host and viral factors. This review addresses these and other common forms of viral arthritis, such as that caused by parvovirus B19.
Calabrese
Leonard H
LH
Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic, Cleveland, OH 44195, USA. calabrl@ccf.org
Naides
Stanley J
SJ
D018354:Alphavirus Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D000998:Antiviral Agents / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology / Q000821:virology; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D015490:HTLV-I Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006509:Hepatitis B / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D010322:Parvoviridae Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D012409:Rubella / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy
D000998:Antiviral Agents